Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Community Focus Channel is supported with funding from Johnson & Johnson (Gold).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

iwAL 2026 | Community-academic collaboration in AML management

Amir Fathi, MD, MPH, Massachusetts General Hospital, Boston, MA, discusses the importance of collaboration between community oncologists and academic leukemia centers when managing patients with acute myeloid leukemia (AML). He highlights the value of specialist guidance, close monitoring and prompt management of transfusion needs, infections and bleeding complications. This interview took place at the 8th International Workshop on Acute Leukemias (iwAL 2026), held in Boston, MA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

I encourage every community practice that is not well-versed in leukemia treatment or does not regularly see these patients to get in touch quickly with an academic center that has leukemia expertise. Not necessarily because we will be taking over the patient’s care, but because we think we can help, provide guidance, provide help and support over the course of the treatment for the patient...

I encourage every community practice that is not well-versed in leukemia treatment or does not regularly see these patients to get in touch quickly with an academic center that has leukemia expertise. Not necessarily because we will be taking over the patient’s care, but because we think we can help, provide guidance, provide help and support over the course of the treatment for the patient. And there are some concerns about patients being treated in the community closer to their home without leukemia expertise surrounding them. It may be convenient, it may be easier, but we also want to make sure that the patient is followed closely, that they are receiving transfusions when they need to, and that they are being managed for any potential infectious or bleeding complications immediately so that it does not become an issue. So close involvement with an academic center is very good combined with care closer to home.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.